About mySugr
mySugr is a Healthcare company based in Vienna (Austria) founded in 2012, and was acquired by Roche in June 2017. Gamified apps for diabetes management and therapy are provided. It operates on a Freemium and HealthTech model in Healthcare and Technology sectors. mySugr has raised $4.8 million across 2 funding rounds from investors including Roche, Gotthardt Healthgroup and iSeed Ventures. Its website mysugr.com draws about 143 thousand monthly visits. mySugr offers products and services including mySugr App, mySugr Bolus Calculator, and mySugr Pump Control. Its focus areas include Digital Health and Diabetes Management. Its legal entity is mySugr GmbH.
Company details
mySugr is dedicated to easing the daily challenges of diabetes management. The company offers a digital health app designed for people with diabetes, created by individuals with diabetes. Solutions include personalized logging, blood glucose meter connectivity, bolus calculators, and pump control features. Since joining the Roche family in 2017, mySugr has expanded its reach to support individuals with diabetes and other chronic conditions globally. The app integrates with devices like Accu-Chek meters and provides secure data handling under GDPR standards. It operates in the healthcare sector, specifically targeting digital health and diabetes care.
- Headquarters Vienna, Austria
- Stage Acquired
- SectorsHealthcareTechnology
- Phoneβ’β’β’β’ β’β’β’β’
- Website mysugr.com/en-us
- Social LinkedIn X Facebook
- Acquired by Roche (Jun 2017)
- Legal Name Mysugr Gmbh
Products & Services of mySugr
mySugr offers a comprehensive portfolio of products and services, including mySugr App, mySugr Bolus Calculator, and mySugr Pump Control.
Diabetes management app for tracking and logging data.
Tool for calculating insulin doses for meals accurately.
Feature for controlling insulin pumps via app interface.
Apps and channels of mySugr
mySugr publishes 2 mobile apps with over 5M+ downloads.
Funding Insights of mySugr
mySugr has successfully raised a total of $4.8M across 2 strategic funding rounds. The most recent funding activity was a Seed round of $4.8 million completed in March 2015. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $4.8M
- Total Rounds 2
- Last Round Seed β $4.8M
- Investors Count 4
All 2 funding rounds of mySugr with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Mar 2015 | $4.8M | Seed | β | iSeed Ventures, Roche | |
| Jan 2012 | Angel Round | β | β | β |
5 investors in total: 4 institutional and 1 angel.
Investors in mySugr
mySugr has secured backing from 5 investors, including venture fund, institutional, and angel investors. Prominent investors backing the company include Roche, Gotthardt Healthgroup and iSeed Ventures.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Venture capital firm investing in AI and digital health startups based in San Francisco. | iseedvc.com | |||
Corporate-backed venture capital firm focused on the healthcare sector | roche.com/venturefund.htm | |||
Software solutions for clinical trials are developed by Gotthardt Healthgroup. | 2015 | gotthardt.com | Heidelberg, Germany | |
Pharmaceuticals and diagnostics kits are developed for various diseases. | 1896 | roche.com | Basel, Switzerland | |
HH Hansi Hansmann | unknown_53cf9f85e2874f31a |
Investor details for mySugr
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of mySugr
6 people are tracked at mySugr (5 in leadership, 1 in team).
| Name | Role | Group |
|---|---|---|
Stephan Silbermann | Medical Director | Leadership |
Elisabeth Kölbel | Managing Director | Leadership |
Daniel Getta | Head of Finance | Leadership |
Birgit Richter | Managing Director, Trade Law & Head of Regulatory Affairs | Leadership |
Nilo Paredes | Global Head of Digital Engineering | Leadership |
Pascal Hofer | Legal Counsel | Team |
Complete people profiles for mySugr
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of mySugr
4 dated milestones of mySugr across 5 years, from founding to its latest funding, stage changes and deals.
- Founded mySugr is founded.
- Funding First funding round.
- Funding Latest funding round, Seed, of $4.8M.
- Exit Acquired by Roche.
Web traffic of mySugr
The website of mySugr (mysugr.com) receives about 143.2K visits a month.
- Monthly visits143.2K
▼ 8.3% vs previous month
Websites whose visitors overlap most with mySugr. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
diabetes.ufl.edu | diabetes.ufl.edu | 100% | β | ||
diabetesde.org | diabetesde.org | 86% | #520,766 | β | |
| diabetes-kids.de | 84% | #1,970,273 | View details | ||
diabetesforecast.org | diabetesforecast.org | 78% | β | ||
diabetesvic.org.au | diabetesvic.org.au | 78% | #1,158,605 | β | |
| β’β’β’β’β’β’β’β’β’β’ | β’β’β’β’β’β’.com | β’β’% | β’.β’M | #β’β’β’β’β’ | β |
| β’β’β’β’β’β’β’β’β’β’ | β’β’β’β’β’β’.com | β’β’% | β’.β’M | #β’β’β’β’β’ | β |
| β’β’β’β’β’β’β’β’β’β’ | β’β’β’β’β’β’.com | β’β’% | β’.β’M | #β’β’β’β’β’ | β |
All 40 similar websites and full traffic analytics for mySugr
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 40 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track β from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Mysugr
Complete news archive for mySugr
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about mySugr
mySugr was founded in 2012.
mySugr is headquartered in Vienna, Austria.
mySugr is a funded company, having raised a total of $4.8M across 2 funding rounds to date.
mySugr is dedicated to easing the daily challenges of diabetes management. The company offers a digital health app designed for people with diabetes, created by individuals with diabetes. Solutions include personalized logging, blood glucose meter connectivity, bolus calculators, and pump control features. Since joining the Roche family in 2017, mySugr has expanded its reach to support individuals with diabetes and other chronic conditions globally. The app integrates with devices like Accu-Chek meters and provides secure data handling under GDPR standards. It operates in the healthcare sector, specifically targeting digital health and diabetes care.
mySugr offers mySugr App, mySugr Bolus Calculator, and mySugr Pump Control.
mySugr has 5 investors. Key investors include Roche, Gotthardt Healthgroup, iSeed Ventures, Roche, and Hansi Hansmann.
mySugr operates through Mysugr Gmbh.
Yes. mySugr was acquired by Roche in June 2017.
Yes. mySugr publishes mySugr - Diabetes Tracker Log and 1 more app, with over 5 million downloads.
The website of mySugr receives about 143 thousand visits a month.

